FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200437730> ?p ?o ?g. }

• W4200437730 abstract "BACKGROUNDLong-term prognosis of WHO grade II low-grade gliomas (LGGs) is poor, with a high risk of recurrence and malignant transformation into high-grade gliomas. Given the relatively intact immune system of patients with LGGs and the slow tumor growth rate, vaccines are an attractive treatment strategy.METHODSWe conducted a pilot study to evaluate the safety and immunological effects of vaccination with GBM6-AD, lysate of an allogeneic glioblastoma stem cell line, with poly-ICLC in patients with LGGs. Patients were randomized to receive the vaccines before surgery (arm 1) or not (arm 2) and all patients received adjuvant vaccines. Coprimary outcomes were to evaluate safety and immune response in the tumor.RESULTSA total of 17 eligible patients were enrolled - 9 in arm 1 and 8 in arm 2. This regimen was well tolerated with no regimen-limiting toxicity. Neoadjuvant vaccination induced upregulation of type-1 cytokines and chemokines and increased activated CD8+ T cells in peripheral blood. Single-cell RNA/T cell receptor sequencing detected CD8+ T cell clones that expanded with effector phenotype and migrated into the tumor microenvironment (TME) in response to neoadjuvant vaccination. Mass cytometric analyses detected increased tissue resident-like CD8+ T cells with effector memory phenotype in the TME after the neoadjuvant vaccination.CONCLUSIONThe regimen induced effector CD8+ T cell response in peripheral blood and enabled vaccine-reactive CD8+ T cells to migrate into the TME. Further refinements of the regimen may have to be integrated into future strategies.TRIAL REGISTRATIONClinicalTrials.gov NCT02549833.FUNDINGNIH (1R35NS105068, 1R21CA233856), Dabbiere Foundation, Parker Institute for Cancer Immunotherapy, and Daiichi Sankyo Foundation of Life Science." @default.
• W4200437730 created "2021-12-31" @default.
• W4200437730 creator A5006262715 @default.
• W4200437730 creator A5013092869 @default.
• W4200437730 creator A5014709556 @default.
• W4200437730 creator A5019140507 @default.
• W4200437730 creator A5021442843 @default.
• W4200437730 creator A5025137523 @default.
• W4200437730 creator A5033073004 @default.
• W4200437730 creator A5038354675 @default.
• W4200437730 creator A5039499539 @default.
• W4200437730 creator A5043536050 @default.
• W4200437730 creator A5045031619 @default.
• W4200437730 creator A5048998314 @default.
• W4200437730 creator A5051168746 @default.
• W4200437730 creator A5052248018 @default.
• W4200437730 creator A5054330196 @default.
• W4200437730 creator A5058793243 @default.
• W4200437730 creator A5065465191 @default.
• W4200437730 creator A5071216293 @default.
• W4200437730 creator A5074051971 @default.
• W4200437730 creator A5076038018 @default.
• W4200437730 creator A5083711110 @default.
• W4200437730 creator A5090305344 @default.
• W4200437730 creator A5091257992 @default.
• W4200437730 creator A5091441085 @default.
• W4200437730 creator A5091736003 @default.
• W4200437730 date "2022-02-01" @default.
• W4200437730 modified "2023-09-30" @default.
• W4200437730 title "Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas" @default.
• W4200437730 cites W1575993552 @default.
• W4200437730 cites W1812256879 @default.
• W4200437730 cites W2040827479 @default.
• W4200437730 cites W2065148109 @default.
• W4200437730 cites W2069220906 @default.
• W4200437730 cites W2094735628 @default.
• W4200437730 cites W2096946132 @default.
• W4200437730 cites W2104005232 @default.
• W4200437730 cites W2110632746 @default.
• W4200437730 cites W2116638587 @default.
• W4200437730 cites W2119838967 @default.
• W4200437730 cites W2126432160 @default.
• W4200437730 cites W2126817554 @default.
• W4200437730 cites W2137405984 @default.
• W4200437730 cites W2139791763 @default.
• W4200437730 cites W2140738072 @default.
• W4200437730 cites W2142207707 @default.
• W4200437730 cites W2147387301 @default.
• W4200437730 cites W2148977460 @default.
• W4200437730 cites W2163838780 @default.
• W4200437730 cites W2172192343 @default.
• W4200437730 cites W2263206910 @default.
• W4200437730 cites W2366536035 @default.
• W4200437730 cites W2497069555 @default.
• W4200437730 cites W2522948376 @default.
• W4200437730 cites W2596261790 @default.
• W4200437730 cites W2607211817 @default.
• W4200437730 cites W2779736932 @default.
• W4200437730 cites W2794480084 @default.
• W4200437730 cites W2796207838 @default.
• W4200437730 cites W2808236053 @default.
• W4200437730 cites W2878436114 @default.
• W4200437730 cites W2899073628 @default.
• W4200437730 cites W2911752971 @default.
• W4200437730 cites W2913623258 @default.
• W4200437730 cites W2942610007 @default.
• W4200437730 cites W2951912016 @default.
• W4200437730 cites W2966465234 @default.
• W4200437730 cites W2990308980 @default.
• W4200437730 cites W3030339055 @default.
• W4200437730 cites W3032465961 @default.
• W4200437730 cites W3080758869 @default.
• W4200437730 cites W4211220688 @default.
• W4200437730 doi "https://doi.org/10.1172/jci151239" @default.
• W4200437730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34882581" @default.
• W4200437730 hasPublicationYear "2022" @default.
• W4200437730 type Work @default.
• W4200437730 citedByCount "22" @default.
• W4200437730 countsByYear W42004377302022 @default.
• W4200437730 countsByYear W42004377302023 @default.
• W4200437730 crossrefType "journal-article" @default.
• W4200437730 hasAuthorship W4200437730A5006262715 @default.
• W4200437730 hasAuthorship W4200437730A5013092869 @default.
• W4200437730 hasAuthorship W4200437730A5014709556 @default.
• W4200437730 hasAuthorship W4200437730A5019140507 @default.
• W4200437730 hasAuthorship W4200437730A5021442843 @default.
• W4200437730 hasAuthorship W4200437730A5025137523 @default.
• W4200437730 hasAuthorship W4200437730A5033073004 @default.
• W4200437730 hasAuthorship W4200437730A5038354675 @default.
• W4200437730 hasAuthorship W4200437730A5039499539 @default.
• W4200437730 hasAuthorship W4200437730A5043536050 @default.
• W4200437730 hasAuthorship W4200437730A5045031619 @default.
• W4200437730 hasAuthorship W4200437730A5048998314 @default.
• W4200437730 hasAuthorship W4200437730A5051168746 @default.
• W4200437730 hasAuthorship W4200437730A5052248018 @default.
• W4200437730 hasAuthorship W4200437730A5054330196 @default.
• W4200437730 hasAuthorship W4200437730A5058793243 @default.
• W4200437730 hasAuthorship W4200437730A5065465191 @default.
• W4200437730 hasAuthorship W4200437730A5071216293 @default.
• W4200437730 hasAuthorship W4200437730A5074051971 @default.

• next